Social Media Ambassador

Dr. Zille Huma is cardiologist with 7 years of work experience in general cardiology both in Pakistan and at Portsmouth hospital, NHS. She has recently completed her training as Interventional cardiology fellow from National Institute of Cardiovascular Diseases, Karachi which is one of the highest volume centres of coronary intervention especially Primary PCI. She aspires to progress her professional journey further in interventional cardiology, with a special interest in intravascular imaging and complex percutaneous coronary interventions (PCI). Furthermore, she has a research interest in Acute Coronary Syndrome (ACS) and is currently engaged in various research projects at NICVD that investigate the outcomes of ACS/PPCI. Dr. Huma also holds a Fellowship with APSIC.

Dr. Muhammad Shuaib Abid graduated with his MBBS from A.I.M.C. Lahore, Pakistan, and passed his fellowship in Cardiology (FCPS) in 2018 from CPSP Karachi. He is currently working as a Senior Registrar at CPE Institute of Cardiology Multan, Pakistan. He is a high-volume interventional cardiologist doing all routine coronary interventions including Primary PCIs. He has further interest in complex PCI, CHIP, Left main, rotablation, and imaging, with a special interest in CTO, Stroke, Vascular and Structural heart disease. He is keen on doing research and has done a Randomized Clinical Trial Course by the American College of Cardiology. He is also an associate editor of PJCVI (Pakistan Journal of Cardiovascular Interventions). Dr. Muhammad Shuaib Abid is currently active in social media and believes that with this modern way of communication, people can easily share knowledge and experience. He is a Social Media Ambassador of TCT, CTO, and has many Facebook pages to deliver his academic cardiology work, 'Sultania Cardiovascular Sciences' and 'Sultania Cardiovascular Interventions.'

To be updated

Dr. Surenjav is a dedicated cardiologist and interventional cardiologist practicing in Mongolia, where he delivers advanced cardiovascular care in a unique healthcare landscape. With a strong passion for precision and innovation, he specializes in multimodality imaging-guided decision making for a wide range of cardiovascular conditions, including coronary artery disease and valvular heart diseases. He is particularly enthusiastic about coronary CT angiography-guided percutaneous coronary intervention (PCI) to optimize outcomes in patients with complex coronary artery disease (CAD). Committed to integrating advanced imaging modalities with interventional procedures, Dr. Surenjav strives to enhance diagnostic accuracy, procedural safety, and long-term patient results. His expertise reflects a forward-thinking approach to modern cardiology, focused on personalized, evidence-based treatments that address the evolving challenges of heart disease in clinical practice.

Dr. Erwin Mulia is an interventional cardiologist based in Lampung Province, Indonesia. His medical journey has taken him across various regions, starting with medical school in Bali, followed by cardiology training in Jakarta. He then advanced his expertise in interventional cardiology in Malaysia Borneo, before returning to the southern part of Sumatra island to continue his work in Lampung.
For the past six years, Dr. Mulia has served as the head of the Invasive Cardiac Laboratory at Ahmad Yani Metro Hospital, which provides care to approximately one-third of Lampung’s population, around 3 million people. His professional passions and primary areas of interest include CT-guided PCI, CTO PCI, device therapy, vascular diseases, and complications.
Though Dr. Mulia describes himself as somewhat introverted, he is also an easy-going individual with an open mind, eager to learn new things and build lasting relationships with colleagues and peers throughout his career. Outside of his cardiology work, he is an avid fan of crime fiction, particularly the works of David Baldacci, Lee Child, and Harlan Coben. He is also a dedicated soccer fan, supporting teams such as AC Milan, Manchester United, and Barcelona.
Looking ahead to 2026, Dr. Mulia hopes to make significant contributions in the fight against cardiovascular diseases. He aims to share the latest treatment advancements, supported by scientific data, at CVRF conferences to help tackle the growing challenges of cardiovascular health.

Dr. Hany Ragy, graduated in Cairo in 1980, trained in USA, Holland, and Germany. He was an ex-head of Cardiology Department at Egypt’s largest cardiology hospital the National Heart Institute. He is a high-volume interventional cardiologist in both coronary interventions and mitral balloon Valvuloplasty, including invasive and non-invasive imaging and physiology. In addition, he recently shifted his interest to prevention and combatting NCD’s and help leading the NGO efforts in Egypt. He has featured in numerous publications and currently active on social media.

Dr Markz Sinurat, MD, FIHA, is a cardiologist with an educational background from Universitas Padjadjaran, Indonesia. He is currently completing a fellowship at Korea University Medical Center (KUMC), Guro Hospital, where he specializes in complex coronary and peripheral intervention procedures. His area of research interests include peripheral vascular disease, particularly BTK and BTA, and aortic disease.
Dr. Sinurat is a Fellow of the Indonesian Heart Association (FIHA) and a member of the Vascular Medicine Working Group. He is committed to advancing medical treatment and research in cardiology and vascular medicine.
As a CVRF Social Media Ambassador, Dr. Sinurat aims to share his valuable insights and experiences with the global community to promote advances in cardiology and vascular medicine research and practice.

Dr.Thanawat Suesat is currently a consultant intervention cardiologist and internal medicine physician at Khon Kaen Hospital, Thailand, and he is a member of the Cardiovascular Intervention Association of Thailand (CIAT). He specializes in complex and high-risk coronary intervention (CHIP), CTO, Left main, bifurcation, and Rotablation using intravascular imaging. He is also interested in congenital and structural heart intervention, like Percutaneous closure of ASD/PFO, PDA and VSD, mitral valve, and pulmonic valve balloon valvuloplasty. Dr. Thanawat has actively participated in various interventional cardiology conferences as a speaker, live case operator, panelist, and invited faculty.

Dr. Indah Sukmawati is an Indonesian Cardiologist with an interest in interventional cardiology and complex coronary interventions which she is currently undergoing training in National University Heart Centre Singapore. Upon completion of the training, she will return to Siloam Hospitals Lippo Village and Universitas Pelita Harapan in Tangerang - Indonesia to serve as interventional cardiologist and as staff lecturer. She is actively involved in Indonesian Heart Association (IHA) as Secretary for Woman Cardiology Task Force. Dr. Sukmawati also enjoys being involved as Social Media Consultant for JACC Case Reports and Social Media Editor for The Indonesian Society of Interventional Cardiology. She also serves as Head of Book Publishing Team in Banten Chapter of IHA which she had helped her colleagues to publish 31 cardiology books and 1 laymen heart health education book. She had authored and co-authored 3 books and served as primary editor for 3 books.

Filling a unique position in the interventional cardiology community, Mona Tirén has developed a sound reputation as a strategic partner, global liaison and knowledge hub. Her work supports physicians’, medical societies’ and industry’s efforts to improve patient care. Key long-standing relationships and a vast network, along with continuous assessment of the medical landscape, have been fundamental to engaging expert clinicians and researchers, and enabling insights and identification of trends in clinical practice. Areas of work include: strategic dissemination of scientific and clinical information, coordination of interaction with opinion leaders, advisory board development and facilitation, meeting strategy and promotion, publication plans and medical congress strategies, medical symposia, education strategy and materials development, scientific communication strategy and materials, and evidence generation strategies. Of particular interest are coronary physiology and intravascular imaging, where Mona Tirén’s niche expertise is unparalleled. With experience from start-up to large corporation, past roles include head of global Clinical Marketing for St Jude Medical, covering heart failure, heart rhythm disorders, vascular disease, structural heart disease, chronic pain and movement disorders; and pioneering work in the field of intravascular pressure sensors and physiological assessment at RADI Medical Systems.

Dr. Tri Loc Vu is a cardiologist and clinical researcher at Tan Tao University with expertise in coronary physiology, cardiovascular fluid dynamics, and AI-driven imaging. He integrates advanced hydraulic principles to better understand the mechanisms of coronary artery disease. His work has been internationally recognized with the AHA Paul Dudley White International Scholar Award for four consecutive years (2021-2024), AHA top-scoring abstracts (2022), and the Best Abstract Award from the Vietnam National Heart Association (2024). In 2025, Dr. Vu was elected a Fellow of the American College of Cardiology (FACC). As an active American Heart Association volunteer, Dr. Vu serves on the 2026 Grant Fellowship and Innovative Project Award Review Committees. Beyond research, he is the founder of a physician-led digital platform reaching over 130,000 medical professionals, dedicated to translating late-breaking cardiovascular science and global guidelines into real-world practice across Vietnam and Southeast Asia.

Dr. Wittawat Wattanasiriporn is a dedicated Interventional Cardiologist. As a Lecturer and Consultant at Rajavithi Hospital, College of Medicine, Rangsit University, he actively contributes to medical education, case presentations, and research on a global scale. He strives to make a significant impact in advancing interventional cardiology to enhance patients' quality of life.